← Back to Search

Financial Incentives for Smoking Cessation

N/A

Waitlist Available

Led By Darla E. Kendzor, PhD

Research Sponsored by University of Oklahoma

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 12 weeks post-quit-date

Awards & highlights

Study Summary

This trial will test if small financial incentives can help people in poverty quit smoking. 160 people will be enrolled and followed to see if the incentives help them quit.

Who is the study for?

This trial is for adults who smoke at least 5 cigarettes daily, are over 18, live in one of the 16 persistent poverty counties in Oklahoma, and want to quit smoking through the Oklahoma Tobacco Helpline. They must be able to provide ID proof, read and speak English, and have no issues using nicotine replacement therapy.Check my eligibility

What is being tested?

The study tests if small financial rewards can help people stop smoking when added to standard care. Participants will receive counseling from the Oklahoma Tobacco Helpline and could get money for attending sessions and not smoking.See study design

What are the potential side effects?

There may not be direct medical side effects from participating; however, participants might experience stress or frustration related to quitting smoking or due to the process of trying to meet criteria for financial incentives.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 12 weeks post-quit-date

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~12 weeks post-quit-date

This trial's timeline: 3 weeks for screening, Varies for treatment, and 12 weeks post-quit-date for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Cost-effectiveness

Measure

Secondary outcome measures

Self-reported smoking abstinence

Side effects data

From 2012 Phase 4 trial • 122 Patients • NCT01513330

Peristomal skin redness

Granulation in the peristomal area

Peristomal allergic contact dermatitis

Peristomal burns

Peristomal skin erosion

Diarrhoea

Pain in the peristomal area

Itching

100%

80%

60%

40%

20%

Study treatment Arm

SenSura Mio

Standard Care

Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: Standard Care + Financial IncentivesExperimental Treatment2 Interventions

Financial Incentives participants will receive standard care for completing counseling calls.

Group II: Standard CareActive Control1 Intervention

Participants randomized to Standard Care will be offered weekly counseling calls and pharmacotherapy.

Treatment

First Studied

Drug Approval Stage

How many patients have taken this drug

Standard Care + Financial Incentives

2017

N/A

~490

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

University of OklahomaLead Sponsor

455 Previous Clinical Trials

95,755 Total Patients Enrolled

Darla E. Kendzor, PhDPrincipal InvestigatorUniversity of Oklahoma

2 Previous Clinical Trials

552 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there any vacancy positions in this research experiment that participants can join?

"According to clinicaltrials.gov, the recruitment phase for this medical trial closed on October 3rd 2022; its initial posting was made March 9th of that year. Nevertheless, there are presently 98 other ongoing clinical trials searching for suitable candidates."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Incentives for Smoking Cessation in Persistent Poverty Counties

2022. "Incentives for Smoking Cessation in Persistent Poverty Counties". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05095779.